Loading stock data…
ABEO
$5.34-0.11 (-1.93%)
Market OpenUpdated 1:29 PM EDT
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Abeona Therapeutics Inc. in the Healthcare sector is trading at $5.34. Wall Street consensus targets $19.71 (7 analysts), implying a +268.8% move over the next 12 months. The stock is currently 29% below its 52-week high of $7.54, remaining 1.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +268.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.72M↑ | $5.42M | $0↓ | $400,000 | $0 |
| Gross Profit | $6.02M↑ | $2.58M↑ | -$488,000↓ | $300,000 | $0 |
| Operating Income | -$23.03M↓ | -$22.91M↑ | -$24.02M↓ | -$22.79M↓ | -$19.73M |
| Net Income | -$17.07M↑ | -$20.46M↓ | -$5.16M↓ | $108.83M↑ | -$12.03M |
Peer Comparison
JNJUNHPFE
Fundamentals
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients wi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
45.63%
Volume
Today's trading volume
505,628
Recent News
3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings Growth
Over the last 7 days, the United States market has dropped by 2.5%, yet it has risen by 23% over the past year, with earnings expected to grow by 17% annually in the coming years. In this context of fluctuating performance and anticipated growth, stocks with high insider ownership can be appealing as they often signal confidence from those closest to the company's operations and potential for substantial earnings growth.
Insider Favorites High Growth Companies June 2026
Over the last 7 days, the United States market has dropped 2.5%, yet it remains up by 23% over the past year, with earnings projected to grow by 17% annually in the coming years. In this fluctuating environment, identifying growth companies with high insider ownership can be particularly appealing as these firms often demonstrate strong potential and a vested interest from those who know them best.
Top Growth Companies With Insider Ownership In June 2026
The United States market remained flat over the last week but has seen a robust 26% increase over the past year, with earnings expected to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly attractive as they often indicate strong internal confidence and alignment of interests between management and shareholders.
June 2026's Leading Growth Stocks With Insider Influence
In the past week, the United States market has seen a 1.6% increase and is up an impressive 28% over the last year, with earnings projected to grow by 17% annually in the coming years. In this thriving environment, identifying growth companies with significant insider ownership can be crucial as it often indicates confidence from those closest to the business and aligns their interests with shareholders.
3 Growth Stocks Insiders Are Betting On
Over the last 7 days, the United States market has risen by 1.6%, contributing to a substantial 28% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In this favorable environment, growth companies with high insider ownership can be particularly appealing as insiders often have unique insights into their company's potential and are willing to invest alongside other shareholders.